一个可穿戴系统用于帕金森病的视觉提示步行康复:一个随机的非劣等性试验
Michelangelo Bartolo1, Alberto Castelli2, Marzia Calabrese2
1Neurorehabilitation Unit, Rehabilitation Department, HABILITA Zingonia, Zingonia, Bergamo, Italy - bartolomichelangelo@gmail.com.
European journal of physical and rehabilitation medicine
|March 14, 2024
概括
一个新的可穿戴视觉暗示系统 (Q-Walk) 有效地改善了帕金森病患者的步态,显示了与传统方法相比的非劣势. 这项技术为持续的个性化康复提供了一种可行且有动力的方法.
科学领域:
- 神经学 神经学
- 康复医学 康复医学 康复医学
- 生物医学工程 生物医学工程
背景情况:
- 步态障碍是帕金森病 (PD) 中的主要致残症状.
- 当前的康复策略通常依赖于传统的视觉线索,例如地板标记.
- 需要创新,可访问的解决方案来改善PD患者的步态.
研究的目的:
- 评估Q-Walk可穿戴视觉暗示系统与帕金森病患者步行康复的传统视觉暗示相比的非劣势.
- 评估Q-Walk系统的可行性,有效性和患者满意度.
主要方法:
- 进行了一项开放的,单心的,随机对照的非劣势性试验.
- 患有异常性PD (Hoehn和Yahr阶段II-IV) 的参与者接受了10次物理治疗,使用Q-Walk或传统视觉线索.
- 步行和姿势分析,以及临床评估,在基线,治疗后和3个月后续进行.
主要成果:
- 无论是Q-Walk系统还是传统的线索,都显著改善了PD患者的步态和平衡参数.
- 在步行康复中,Q-Walk系统展示了与传统视觉线索相比的非劣势.
- 患者对Q-Walk系统表示高度满意,理由是它的简单性,动机性和可用性,这表明它有可能用于家庭使用.
结论:
- 可穿戴的Q-Walk系统是帕金森病运动康复的可行和有效工具,与传统方法相比.
- 可穿戴技术为PD患者的持续,个性化和远程康复策略提供了一个有希望的途径.
- 通过在家庭环境中进行密集培训,Q-Walk可以增强长期护理.
更多相关视频
07:21Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease
Published on: June 16, 2023
929
06:25Paw-Print Analysis of Contrast-Enhanced Recordings PrAnCER: A Low-Cost, Open-Access Automated Gait Analysis System for Assessing Motor Deficits
Published on: August 12, 2019
8.5K
相关概念视频
Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
Parkinson's Disease: Overview
541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541
